Internship in Innovation & Sustainability - Life Sciences/Natural Sciences

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections,  where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.

The Position

A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love.  That’s what makes us Roche.

Our Global Internship Programme in Innovation & Sustainability (#IP2TIS) offers a unique opportunity for passionate individuals to gain hands-on experience in the pharmaceutical industry while making a positive impact on the world.

Are you ready to join a global network spanning 20+ countries, where bright minds collaborate to tackle real-world challenges in Innovation & Sustainability? Do you want to work on impactful projects, shape the future, and drive change from within?

The Position

As an intern, you will contribute to a project focused on improving patient retention in Cardiovascular and Metabolism (CVM) clinical trials in China. The project aims to move beyond an enrollment-first mindset by identifying the main drivers of patient attrition, assessing protocol and operational barriers, and translating insights into practical retention strategies. Within your first 3 months, you are expected to deliver a literature review and gap analysis, a retention factor matrix tailored to the China CVM setting, strategic recommendations, and an implementation roadmap for future studies. You will also help transform recurring project activities into reusable digital assets by leveraging AI platforms and large language models to support literature intelligence gathering, meeting insight extraction, and workflow standardization. Your work will contribute to more robust, complete, and representative trial data, helping Roche bring innovative CVM medicines to patients more effectively.

The Opportunity

• Conduct literature and intelligence searches to identify commonly used approaches to patient retention in clinical trials.

• Participate in study team meetings to understand retention challenges and operational barriers in CVM trials in China.

• Join discussions with internal partners and external vendors on patient retention topics, take meeting minutes, and prepare clear summary reports.

• Report project progress regularly to the country Therapeutic Area Leader.

• Support the team in exploring and implementing practical solutions to improve patient retention.

• Analyze patient attrition drivers such as visit burden, logistical barriers, and communication gaps.

• Help translate operational activities into reusable digital assets using available AI platforms and LLMs.

• Contribute to building standardized AI skills or agents that improve long-term team efficiency in literature review and insight generation.

Who You Are

You are enrolled in your Bachelor’s or Master’s studies at a university, preferably in the field of Life Sciences/Natural Sciences and are interested in applying your knowledge in a modern working environment as part of an internship of 3 months.

Furthermore you are

• Studying Life Sciences or a related field and have a strong interest in AI and technology.

• Interested in using available AI platforms and large language models to support practical workflow improvement.

• Curious, eager to learn, and able to work independently while adapting to new topics quickly.

• A collaborative team player with strong communication skills.

• Fluent in Chinese; English is a plus.

If you meet most but not all qualifications, we still encourage you to apply.

Additional information

The internship is expected to start between 1 and 16 July 2026 and will last 3 months.

For more information about IP2TIS and to explore other opportunities within the programme, please visit go.roche.com/ip2tis_26

Who we are

A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.

Let’s build a healthier future, together.

Roche is an Equal Opportunity Employer.